570 Safety and Efficacy of Bertilimumab, a Human Anti-Eotaxin-1 Monoclonal Antibody, in Bullous Pemphigoid in a Phase 2a Study
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.646
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV